• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PRTK

PRTK

Paratek Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.23

+0.04 (+1.83%)

Company Profile

CEO

Evan Loh FACC, FAHA,

IPO Date

2009-02-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.19

Prev. Close

$2.19

Day Low

$2.19

Day High

$2.24

52W Low

$1.29

52W High

$3.65

Market Cap

$0.13B

Volume

4.48M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

54.0%

Avg Negative

11.9%

Avg Neutral

34.2%

News Feed

Why Paratek Pharmaceuticals Stock Is Sinking Today

The Motley Fool·6/16/2021·↓ negative

Paratek Pharmaceuticals Announces Initiation of Phase 2b Study in Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc) with NUZYRA® (omadacycline)

GlobeNewsWire·6/16/2021·↑ positive

Why Paratek Pharmaceuticals Crushed the Market Today

The Motley Fool
·6/1/2021
·↑ positive

Paratek's Stock Gains After Nuzyra's Oral Regime Wins FDA Approval For Pneumonia

Benzinga·6/1/2021·↑ positive

Paratek Pharmaceuticals Announces FDA Approval of NUZYRA® (omadacycline) Oral Only Dosing Regimen for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)

GlobeNewsWire·6/1/2021·↑ positive

Paratek Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference

GlobeNewsWire·5/26/2021·↑ positive

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/17/2021·↓ negative

Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research·5/17/2021·↑ positive

Paratek Pharmaceuticals: Q1 Earnings Insights

Benzinga·5/17/2021·↑ positive

Paratek Pharmaceuticals Announces First Quarter 2021 Total Revenue of $16.4 Million and Initiation of First BARDA Procurement

GlobeNewsWire·5/17/2021·↑ positive